Delivery Order SPE2DB24D1104-SPE2DB26FXTF0
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,339.14. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The order is scheduled for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ketorolac 15 mg/ml vials at a firm fixed price ceiling value of $1,476.08. This is an unset-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,858.48. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order...
- The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $10,570.63 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 19, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,616.58 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. This prime IDV, valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.70 to AmerisourceBergen Drug Corp for the supply of Ketorolac 60 mg/2 mL vials on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order, which was not set-aside, represents a single transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ketorolac 30 mg/ml vials with a ceiling value of $1,571.57. The contract utilizes firm fixed pricing and carries an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB26FXTF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,548.80 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This competitive, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company has demonstrated extensive capability in supplying pharmaceutical products and medical supplies through multiple competitive awards with the Defense Logistics Agency. The SPE2DX prime contract vehicle enables AmerisourceBergen to furnish a comprehensive range of pharmaceuticals, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare operations globally. This delivery order for Ketorolac, a nonsteroidal anti-inflammatory pain management pharmaceutical, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/16/25 |